Bud Light used an actor dressed as a medieval town crier last week to ask a Minnesota brewery to stop using the company’s trademarks, becoming the latest brand to transform a cease-and-desist into a marketing stunt.
Roxane drops challenge to patent and agrees not to seek approval to market product until patent expires in 2014.
Complaint concerns a patented auto-status technology used by concrete truck fleets.
Companies agree to cross-license patent estates for herbicide tolerance and insect resistance technologies.
China is major target for Japan's gaming software industry.
In a highly unusual turn of events, lawyers for two companies in a patent dispute have themselves been pulled into the litigation.
Tyco Electronics had accused Bourns of misappropriating trade secrets and interfering with employee contracts.
ACTV, now part of OpenTV Corp., had accused Disney, along with subsidiaries ABC and ESPN, of infringing three patents for linking television with the internet.
Lundbeck agrees to licence patents to Sandoz for certain territories and pulls claims of forgery and perjury against Matrix Laboratories.
University Center on Intellectual Property to function as branch of the WIPO Worldwide Academy.
Proposals would ban patents on diagnostic, therapeutic and surgical methods.
SanDisk vows to immediately take steps to appeal the decision to the Federal Circuit Court of Appeals.
Dispute over platform allowing customers to download music tracks for a fee using Microsoft's Windows Media Player.
But Scottish technology company expects a two-day delay, and backers question timing of lawsuit.
Taskforce will train police, conduct public awareness campaigns and recommend legal and judicial reforms.
Jury finds insurance agency exceeded authorized use of web-based calculator developed by independent programmer.
Police credits campaign with changing attitudes among corporate software buyers.
Ortho Tri-Cyclen Lo oral contraceptive has $110 million in annual sales.
"Modest changes" to Windows and Internet Explorer after Microsoft setback in Eolas suit.
Ontario argues that a gene molecule is patentable but not the genetic information contained in the molecule.
IRS suspects patent donations are frequently overvalued; Congress prepares legislation to address issue.